Aileron Therapeutics Inc (ALRN)
4.92
-0.08
(-1.60%)
USD |
NASDAQ |
Apr 29, 16:00
4.92
0.00 (0.00%)
After-Hours: 20:00
Aileron Therapeutics Price to Book Value: 12.12 for April 29, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 12.12 |
| April 26, 2024 | 12.32 |
| April 25, 2024 | 12.32 |
| April 24, 2024 | 12.15 |
| April 23, 2024 | 11.71 |
| April 22, 2024 | 11.71 |
| April 19, 2024 | 11.68 |
| April 18, 2024 | 12.32 |
| April 17, 2024 | 10.47 |
| April 16, 2024 | 13.18 |
| April 15, 2024 | 14.61 |
| April 12, 2024 | 15.13 |
| April 11, 2024 | 4.051 |
| April 10, 2024 | 4.122 |
| April 09, 2024 | 4.178 |
| April 08, 2024 | 4.398 |
| April 05, 2024 | 4.015 |
| April 04, 2024 | 4.185 |
| April 03, 2024 | 4.143 |
| April 02, 2024 | 4.285 |
| April 01, 2024 | 4.157 |
| March 28, 2024 | 4.703 |
| March 27, 2024 | 4.917 |
| March 26, 2024 | 4.044 |
| March 25, 2024 | 4.171 |
| Date | Value |
|---|---|
| March 22, 2024 | 4.398 |
| March 21, 2024 | 4.022 |
| March 20, 2024 | 3.902 |
| March 19, 2024 | 3.809 |
| March 18, 2024 | 3.838 |
| March 15, 2024 | 3.958 |
| March 14, 2024 | 3.923 |
| March 13, 2024 | 3.951 |
| March 12, 2024 | 3.724 |
| March 11, 2024 | 3.937 |
| March 08, 2024 | 4.136 |
| March 07, 2024 | 4.015 |
| March 06, 2024 | 3.894 |
| March 05, 2024 | 3.937 |
| March 04, 2024 | 3.738 |
| March 01, 2024 | 3.547 |
| February 29, 2024 | 3.504 |
| February 28, 2024 | 3.348 |
| February 27, 2024 | 3.221 |
| February 26, 2024 | 3.320 |
| February 23, 2024 | 3.292 |
| February 22, 2024 | 3.405 |
| February 21, 2024 | 3.308 |
| February 20, 2024 | 3.348 |
| February 16, 2024 | 3.327 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3073
Minimum
Mar 30 2023
15.26
Maximum
Jan 25 2021
2.093
Average
1.082
Median
May 06 2022
Price to Book Value Benchmarks
| EyePoint Pharmaceuticals Inc | 3.299 |
| INVO Bioscience Inc | -- |
| Bio-Path Holdings Inc | 4.387 |
| SINTX Technologies Inc | 0.7622 |
| NovaBay Pharmaceuticals Inc | 1.832 |
Price to Book Value Related Metrics
| Price | 4.92 |
| Earnings Yield | -69.31% |
| Market Cap | 83.50M |